share_log

Canaccord Genuity Assumes Theratechnologies at Hold, Announces Price Target of $2

Canaccord Genuity Assumes Theratechnologies at Hold, Announces Price Target of $2

Canaccord Genuity 假設 TheraTechnologies 處於停滯狀態,宣佈目標
Benzinga ·  2023/07/03 09:02

Canaccord Genuity analyst Edward Nash assumes Theratechnologies (NASDAQ:THTX) with a Hold rating and announces Price Target of $2.

Canaccel Genuity分析師愛德華·納什假設Therattech(納斯達克:THTX)持有評級,並宣佈目標價為2美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論